Normal prothrombin times in the presence of therapeutic levels of apixaban--in-vivo experience from King's College Hospital

Br J Haematol. 2015 Apr;169(1):152-3. doi: 10.1111/bjh.13187. Epub 2014 Oct 14.

Authors

Jignesh P Patel¹, Paradzai B Chitongo, Julia Czuprynska, Lara N Roberts, Raj K Patel, Roopen Arya

Affiliation

¹ King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK; Institute of Pharmaceutical Science, King's College London, London, UK. jig.patel@kcl.ac.uk.

PMID: 25312941
DOI: 10.1111/bjh.13187

No abstract available

Keywords: apixaban; direct-Xa inhibitors; prothrombin time.

Publication types

Letter

MeSH terms

Factor Xa Inhibitors / administration & dosage
Factor Xa Inhibitors / pharmacokinetics*
Hospitals, University
Humans
Male
Prothrombin Time / methods*
Pyrazoles / administration & dosage
Pyrazoles / pharmacokinetics
Pyridones / administration & dosage
Pyridones / pharmacokinetics

Substances

Factor Xa Inhibitors
Pyrazoles
Pyridones
apixaban